In Brief: Activated Cell Therapy, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Activated Cell Therapy, Inc.: Receives 510(k) clearance from FDA for its "patented cell processing devices used for cell isolation and enrichment," the Mountain View, California firm announces. Consisting of a series of buoyant density solutions and centrifugal devices, ACT's technology "allows the efficient recovery and preparation of important cells, such as stem cells and dendritic cells, from peripheral blood, bone marrow, or cord blood." ACT has clinical studies ongoing to treat patients with breast cancer, leukemia and lymphoma using stem cells from bone marrow and peripheral blood...